Skin Cancer Foundation Responds to FDA’s Proposed Age Restriction on Indoor Tanning


New York, NY (December 18, 2015)— The Skin Cancer Foundation commends the U.S. Food and Drug Administration (FDA) for taking this critical step in skin cancer prevention. By proposing a ban on tanning device use for individuals under 18 and requiring tanning device manufacturers to take additional safety measures, the FDA has recognized the clear and present dangers associated with indoor tanning. Additionally, the Foundation applauds the FDA for acknowledging the dangers posed to adults. The proposed rule calls for individuals 18 and over to sign a consent form prior to engaging in this risky behavior. 

Studies offer definitive evidence that indoor tanning bed use increases skin cancer risk. In fact, those who begin tanning before age 35 increase their risk by almost 75 percent. 

For the past 36 years the Foundation has educated the public about the dangers of indoor tanning. This proposal represents a major shift in awareness about indoor tanning hazards, and the Foundation applauds the FDA for taking this important stance. The Foundation encourages the FDA to finalize this proposed rule, as it’s a critical step in the fight against skin cancer, potentially saving thousands of lives.
 

-- Skin Cancer Foundation Senior Vice President Deborah S. Sarnoff, MD

Read the FDA News Release


About The Skin Cancer Foundation

The Skin Cancer Foundation is the only global organization solely devoted to the prevention, early detection and treatment of skin cancer. The mission of the Foundation is to decrease the incidence of skin cancer through public and professional education and research. Since its inception in 1979, the Foundation has recommended following a complete sun protection regimen that includes seeking shade and covering up with clothing, including a wide-brimmed hat and UV-blocking sunglasses, in addition to daily sunscreen use. For more information, visit SkinCancer.org.